© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 371,497 results that match your search.371,497 results
  • Aerospace and defence supplier Meggitt has sold $300m US private placements at three and five years, according to market sources, with leverage step ups to further protect investors.
  • Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.
  • Zhaoheng Hydropower (Hong Kong) has missed a payment on a 2017 dollar loan. It had extended the maturity on that deal earlier this year.
  • Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.
  • The Shanghai bourse stunned the market on Tuesday after halting Ant Group’s $34bn IPO, a deal which was set to be the largest listing in history. The extraordinary move, likely spurred by comments from Ant’s co-founder Jack Ma that criticised authorities for stifling innovation in China, is expected to delay the listing by at least six months. It will also force investors to revalue the company.
  • Argentine power company Gennaia is at risk of defaulting on its domestic dollar bonds as a result of capital controls issued by the Central Bank of Argentina (BCRA), Fitch said on Tuesday as it slashed the rating on the issuer’s international notes.
  • Fujian Yango Group Co returned with another high yielding bond on Tuesday, making it the only Asian issuer to brave the primary dollar debt market ahead of the US election.
  • Credit Suisse has named Mark Uy as its country manager for the Philippines, effective December 1.
  • It’s a pity the irreversible damage to our world’s lungs through the wanton destruction of its rainforests does not come with the same stark health warning found on a packet of cigarettes. If it did, the world’s largest banks and asset managers might be shamed into giving up their dirty habit.
  • ABS
    Navient and CommonBond both brought private credit student loan ABS deals to the market on the cusp of US elections. Depending on the outcome, lenders will have to navigate a sector fraught with risk as reform supported by the Democrats could tamp down student debt in borrowers’ payment priority.
  • Medalist Partners has parted ways with CIO Brian Herr, who stepped down as CIO and co-head of structured credit and asset finance to take up a role as managing director at financial services company Exos.
  • As Americans went the polls on Tuesday, equity investors were positioning themselves for a decisive Democrat victory and a rally in stocks. While primary markets fell silent across asset classes, the pipeline for SSA bonds will likely spring back to life whatever the result. For riskier asset classes, the immediate future for primary markets is less clear.